GDOL Tampa is an event for patients & caregivers to learn more about GIST, find support, & enhance knowledge to help navigate their cancer journey. Meet with other patients and caregivers and experts, clinicians, and researchers in the study and treatment of GIST.
Even though we weren’t together physically for our biennial Life Fest celebration, we united to spread a message of hope and positive messages while raising GIST awareness across the globe.
As part of our Virtual Life Fest celebration, we hosted a Virtual GIST Do It Walk on Sunday, July 12, 2020. The walk was held in memory of Ted Wolf, who lost his battle with GIST in 2018.
In this webinar, we will be discussing how to interpret your pathology report. We will cover interpretation of all parts of a pathology report, beginning with understanding the final diagnosis and diagnostic comment.
This discussion reviewed CRCI in general, and how a person who is being treated for GIST could be affected. We also talked about strategies that can help ameliorate CRCI, new research on CRCI and GIST. we also gave advice on how cancer survivors can best cope with and care for themselves during this unusual global health event.
Join us at GDOL Seattle, Saturday, February 15, 2020, hosted in partnership with the Seattle Cancer Care Alliance at the Orin Smith Auditorium (Building C) on the University of Washington campus - 850 Republican St., Seattle, Washington.
Dr. Nikhil Guhagarkar discusses the dental and oral complications of drugs used in GIST treatment and treatment of these side effects.
Kathy Sarmiento presents, The A B C’s of Medicare: Everything you need to know. Kathy explains everything from medicare costs and eligibility, to finding the right path for you.
This webcast was originally recorded May 21, 2019. Follow this link for webcast with Hebrew Subtitles. Listen to the webcast - Hebrew subtitles Are you interested in optimizing your treatment? In [...]
Most GIST patients will see a surgeon at some point during their treatment. This webcast will address the issues surrounding the decision to have an operation and considers that surgical options depend on a number of factors such as tumor location, tumor size, tumor number, response to drug therapy, and risk of recurrence.